Anh Phuong Nguyen

Anh Phuong Nguyen

Auto-generated profile, based on publicly available information

Anh Phuong Nguyen

Institute for Health Research, Kaiser Permanente Colorado, Aurora, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Molecular Endocrinology
Verified
Journal Article
Open access
BWBingbing Wang
Bingbing Wang
KPKristy Palomares
Kristy Palomares
NPNataliya Parobchak
Nataliya Parobchak
JCJohn Cece
John Cece
MRMax Rosen
Max Rosen
TRTodd Rosen
Todd Rosen
Our recent study demonstrated that constitutively activated RelB/NF-κB2 positively regulates the CRH in the human placenta. In the current study, we explored the role of the glucocorticoid receptor (GR) signaling in constitutive activation of the noncanonical NF-κB pathway. A glucocorticoid response element (GRE) motif search suggests that both NF-κB inducing kinase (NIK) and RelB genes, which are key regulators of the noncanonical NF-κB pathway, have a putative GRE within their promoter, approximately 1 kb upstream from the transcription start site. By using chromatin immunoprecipitation assay we identified that the GR and phosphorylated GR at Ser211 were associated with the GREs of both NIK and RelB. Dexamethasone stimulated expression of NIK, RelB, NF-κB2 as well as CRH and cyclooxygenase-2 (COX-2). Repression of GR by short interfering RNA resulted in inhibition of NIK, RelB, NF-κB2, CRH, and COX-2. In addition, depletion of GR attenuated glucocorticoid-mediated up-regulation of NIK, RelB, NF-κB2, CRH, and COX-2. Furthermore, siRNA specifically targeting NIK down-regulated CRH and COX-2. Taken together, these results suggest that constitutive activation of the noncanonical NF-κB pathway in term human placenta is driven by the GR signaling, which in turn up-regulates placental CRH and other NF-κB-responsive genes.

2 March 2020 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
ANAnh P. Nguyen
Anh P. Nguyen
JGJason M. Glanz
Jason M. Glanz
KNKomal J. Narwaney
Komal J. Narwaney
IBIngrid A. Binswanger
Ingrid A. Binswanger
Opioid exposure and overdoses among adolescents and young adults (ie, youth) represent a significant public health problem.1-3 Despite state and national efforts to reduce opioid prescribing,4-6 the volume of opioids prescribed to youth and adults remains substantial.7-9 In 2017, more than 191 million opioid prescriptions were dispensed in the United States, more than 3-fold the number prescribed in 1999.9 While overdose risks associated with a number of opioid prescribing patterns at the individual level, such as high dose, have been established,10-13 less is known about exposures to opioids from family members.

8 April 2020 in Addiction
Verified
Journal Article
Closed access
PDF file
IBIngrid A. Binswanger
Ingrid A. Binswanger
ANAnh P. Nguyen
Anh P. Nguyen
JMJeffrey D. Morenoff
Jeffrey D. Morenoff
SXStanley Xu
Stanley Xu
DHDavid Harding
David Harding

13 May 2019 in Nature Human Behaviour
Verified
Journal Article
Closed access
PDF file
DHDavid Harding
David Harding
JMJeffrey D. Morenoff
Jeffrey D. Morenoff
ANAnh P. Nguyen
Anh P. Nguyen
SBShawn D. Bushway
Shawn D. Bushway
IBIngrid A. Binswanger
Ingrid A. Binswanger

26 January 2022 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
ANAnh P. Nguyen
Anh P. Nguyen
JGJason M. Glanz
Jason M. Glanz
JSJo Ann Shoup
Jo Ann Shoup
CCCynthia I. Campbell
Cynthia I. Campbell
CCChristina L. Clarke
Christina L. Clarke
IBIngrid A. Binswanger
Ingrid A. Binswanger

26 July 2024 in Preventive Medicine Reports
Verified
Journal Article
Open access
ANAnh P. Nguyen
Anh P. Nguyen
IBIngrid A. Binswanger
Ingrid A. Binswanger
KNKomal J. Narwaney
Komal J. Narwaney
MFMorgan A. Ford
Morgan A. Ford
DMDavid L. McClure
David L. McClure
JGJason M. Glanz
Jason M. Glanz
Chronic opioid use can lead to detrimental effects on the immune and various organ systems that put individuals prescribed chronic opioid therapy (COT) for pain and those with an opioid use disorder (OUD) at risk for severe COVID-19 disease. We assessed the association of COT and OUD with COVID-19-related hospitalization and death to inform targeted interventions to improve clinical outcomes in COVID-19 patients who use opioids. We conducted a retrospective cohort study of adults ages ≥ 18 with laboratory-confirmed SARS-CoV-2 infection in 2020 and 2021 from three US health systems. We used Cox proportional hazards regression to estimate the 30-day risk of COVID-19-related hospitalization and death associated with two opioid exposures (COT and OUD) following an infection. The study cohort included 53,123 patients with SARS-CoV-2 infection and a mean (SD) age of 45.1 (16.5), of whom 1,059 (2.0 %) were exposed to COT and 269 (0.5 %) had an OUD diagnosis in the year prior to infection. There were 2,270 observed COVID-19-related hospitalizations or deaths (1.6 per 1,000 person-days, 95 % CI 1.5-1.7). In the fully adjusted model, COT was not associated with increased risk (HR 1.19; 95 % CI, 0.98-1.43), while past-year OUD was independently associated with severe COVID-19 disease (HR 1.82; 95 % CI, 1.18-2.80). Past-year OUD remained associated with increased risk in post-hoc analysis with COVID-19-related hospitalization alone as the outcome (HR 2.00; 95 % CI, 1.30-3.08). Past-year OUD is a potential independent risk factor for severe COVID-19 disease that warrants monitoring to improve the prognosis of patients with COVID-19.